Day: December 16, 2025
-
Dec- 2025 -16 DecemberLocal Dynamics
Pharmaceutical Company Declares Highest-Ever Cash Dividend Payout
Hai Phong Pharmaceutical Joint Stock Company (stock code: DPH) has announced its plan to pay a cash dividend for the…
Read More » -
16 DecemberLocal Dynamics
Vietnamese Healthcare Facility Deploys New Generation Diagnostic Imaging Equipment
Phenikaa University Hospital (PhenikaaMec) has officially commissioned the Philips Ingenia Elition X 3 Tesla Magnetic Resonance Imaging (MRI) system. This…
Read More » -
16 DecemberGlobal Trends
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development…
Read More » -
16 DecemberGlobal Trends
Alphyn Biologics Secures $25 Million in Series B Funding
Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was…
Read More » -
16 DecemberGlobal Trends
SOBI Agrees to Acquire Arthrosi Therapeutics
Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly…
Read More » -
16 DecemberM&A
Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories
Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral…
Read More » -
16 December
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
Dren Bio, a privately held, clinical-stage biotechnology company, announced an expanded strategic collaboration with Sanofi for the discovery and development…
Read More » -
16 DecemberGlobal Trends
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with…
Read More » -
16 DecemberGlobal Trends
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
The U.S. Food and Drug Administration (FDA) has “proactively” awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)…
Read More » -
16 DecemberGlobal Trends
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or…
Read More »
